Publications

Show Filters

Searches all publications.

Search Term

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-08-16
    E.g., 2018-08-16

Articles

258333 items
12:00 AM, Jun 05, 1995  |  BC Week In Review | Company News  |  Other News

PerSeptive news

PBIO (Framingham, Mass.) reached an agreement in principle to settle for $12 million the class action securities litigation brought against the company last December after PBIO said it would have to restate its prior financial...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Preclinical Results

Vical, Merck Research Laboratories preclinical data

Merck scientists published animal data with DNA vaccines, showing better efficacy in protecting ferrets from viral challenge than conventional commercial flu vaccines. As reported in Nature Medicine, the DNA vaccines elicited antibodies in non-human...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Regulatory

Celgene regulatory update

Celgene Corp. (CELG)   The FDA granted Orphan Drug designation for Synovir, CELG's thalidomide compound, to treat recurrent aphthous ulcers (canker sores) in immunocompromised patients. Synovir also has Orphan Drug designation to treat clinical manifestations...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Regulatory

Calgene regulatory update

The EPA granted conditional approval of the use of the herbicide bromoxynil in conjunction with CGNE's genetically engineered cotton. EPA granted a three-year approval to bromoxynil-tolerant cotton and limited its planting to a total of...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Regulatory

Lifecore regulatory update

The Chaska, Minn., company received certification of conformance to ISO 9001 Standards and Medical Device Directives as well as the Commission Europeen Mark of Conformity from TUV Product Services of Munich. The designations reflect quality...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Company News  |  Other News

InterMune Life other research news

The Toronto company and the British National Health Service entered into a research agreement to determine the role of INLI's PP14 in the diagnosis of endometrial hyperplasia and endometrial cancers. The work will take...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Company News  |  Other News

GenVec other research news

The Rockville, Md., company entered into two CRADAs with the National Institute on Aging and the cardiology branch of the National Heart, Lung and Blood Institute to accelerate the study of GenVec's adenovirus-mediated gene transfer...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Clinical Status

Virulizin extract of bovine material that stimulates macrophages to release cytokines at tumors update

IMUTF is delaying further its Phase III trial in the cancer and a Phase I/II trial in AIDS. The company initially announced the delay in October and issued a recall of the agent, which had...
12:00 AM, Jun 05, 1995  |  BioCentury | Finance

NeXstar Pharmaceuticals Inc. (NXTR) and U.S. Bioscience Inc. (UBS)

NeXstar Pharmaceuticals Inc. (NXTR) and U.S. Bioscience Inc. (UBS) Market value tracking: The weekly change in the indexed market value of NeXstar Pharmaceuticals Inc. (NXTR, top chart) and U.S. Bioscience Inc. (UBS) compared to The Carson...
12:00 AM, Jun 05, 1995  |  BC Week In Review | Clinical News  |  Regulatory

Noven regulatory update

The Miami company filed an NDA for its transoral mucosal dental anesthetic delivery system. The system is comprised of a thin adhesive strip incorporating lidocaine that is applied directly to the gum or elsewhere in...

Pages